Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. Its Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District Of Columbia.

Danaher Corporation

In a report released on August 12, Nik Modi from RBC Capital maintained a Hold rating on B&G Foods, with a price target of $5.00. The company’s sha...

B&G Foods (BGS) Receives a Hold from RBC Capital

In a report released today, Andrew Lazar from Barclays maintained a Hold rating on B&G Foods, with a price target of $5.00. According to TipRanks, ...

B&G Foods (BGS) Gets a Hold from Barclays

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Danaher (DHR), Vertex Pharmaceuticals (VRTX) and Add...

Analysts’ Top Healthcare Picks: Danaher (DHR), Vertex Pharmaceuticals (VRTX)

In a report released today, Luke Sergott from Barclays maintained a Buy rating on Danaher, with a price target of $230.00. Sergott covers the Healt...

Danaher (DHR) Gets a Buy from Barclays

Danaher ( ($DHR) ) has issued an update. Danaher announced on August 3, 2026 that Executive Vice President Julie Sawyer Montgomery will become pres...

Danaher Announces New CEO and Leadership Transition Plan

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ultragenyx Pharmaceutical (RARE) and Danaher (DHR) w...

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Danaher (DHR)

Evercore ISI analyst David Palmer maintained a Hold rating on B&G Foods today and set a price target of $5.00. According to TipRanks, Palmer is a 4...

Evercore ISI Reaffirms Their Hold Rating on B&G Foods (BGS)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CSL (CMXHF), Danaher (DHR) and TransMedics Group (TM...

Analysts Offer Insights on Healthcare Companies: CSL (OtherCMXHF), Danaher (DHR) and TransMedics Group (TMDX)

The company makes medical diagnostic equipment. 


	A	B	C	D
1	Symbol	Price	Change	Volume
2	DHR	$202.45	-0.71%	2.24M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	DHR	$202.45	-0.7%	2.24M
3
4
5
6

DHR

Get Danaher Corporation Data in Excel

Get Danaher Corporation Data in Excel